Yongquan Shi
Clinical trials sponsored by Yongquan Shi, explained in plain language.
-
Probiotic boost tested to finally beat stubborn stomach bug
Disease control Recruiting nowThis study is for people whose previous treatments failed to clear an H. pylori stomach infection. It tests whether adding a specific probiotic (Saccharomyces boulardii) to a standard 14-day antibiotic regimen makes the treatment more effective and safer. About 1,248 adults who h…
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New trial aims to turn back the clock on Pre-Cancerous stomach change
Disease control Recruiting nowThis study is testing if a medication called ursodeoxycholic acid can reverse a specific change in the stomach lining called intestinal metaplasia, which can increase cancer risk. Researchers will compare the drug to a placebo in about 196 adults who do not have an H. pylori infe…
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Old drug, new hope for cancer Treatment's painful side effect
Symptom relief Recruiting nowThis study is testing whether a combination of two drugs, thalidomide and glutamine, can safely reduce intestinal bleeding in people who developed this complication after radiation therapy for cancer. About 150 adult patients with ongoing bleeding will be randomly assigned to dif…
Phase: PHASE2 • Sponsor: Yongquan Shi • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC